Evidence map›Paper›PMID 27721371›Full record

ArticleBone marrow transplantation2016

GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies.

A Nazha, L Rybicki, D Abounader, B Bolwell, R Dean, A T Gerds, D Jagadeesh, B K Hamilton, B T Hill, M Kalaycio and 5 more

Abstract read
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Impact of Toxicity on Survival for Older Adult Patients after CD34Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 1 institution in 1 country.

A NazhaDepartment of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
L RybickiDepartment of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
D AbounaderDepartment of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
B BolwellDepartment of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
R DeanDepartment of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
A T GerdsDepartment of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
D JagadeeshDepartment of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
B K HamiltonDepartment of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
B T HillDepartment of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
M KalaycioDepartment of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
H LiuDepartment of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
B PohlmanDepartment of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
R SobecksDepartment of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
M A SekeresDepartment of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
N S MajhailDepartment of Hematology and Oncology, Blood and Marrow Transplant Program, Cleveland Clinic, Taussig Cancer Institute, Cleveland, OH, USA.
Cleveland Clinic · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AgedAge FactorsFemaleGraft vs Host DiseaseHematopoietic Stem Cell TransplantationHLA AntigensHumansKaplan-Meier EstimateLeukemia, MyeloidLeukemia, Myeloid, AcuteLeukemia, Myelomonocytic, ChronicMaleMiddle AgedMyelodysplastic SyndromesNeoplasm Recurrence, LocalRetrospective StudiesHLA Antigens

Identifiers

PMID27721371
OpenAlexW2530758424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.